Skribek M[au] - Search Results

Year	Number of Results
2020	1
2021	2
2022	2
2023	2
2024	3
2025	2

1

Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature.

Liu LL, Skribek M, Harmenberg U, Gerling M. Liu LL, et al. Among authors: skribek m. J Immunother Cancer. 2023 Mar;11(3):e005841. doi: 10.1136/jitc-2022-005841. J Immunother Cancer. 2023. PMID: 36878533 Free PMC article. Review.

2

Complications following novel therapies for non-small cell lung cancer.

Skribek M, Rounis K, Tsakonas G, Ekman S. Skribek M, et al. J Intern Med. 2022 Jun;291(6):732-754. doi: 10.1111/joim.13445. Epub 2022 Jan 15. J Intern Med. 2022. PMID: 35032058 Free article. Review.

3

Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis.

Zipprick J, Demir E, Krynska H, Köprülüoğlu S, Strauß K, Skribek M, Hutyra-Gram Ötvös R, Gad AKB, Dobra K. Zipprick J, et al. Among authors: skribek m. Cancers (Basel). 2025 Mar 14;17(6):986. doi: 10.3390/cancers17060986. Cancers (Basel). 2025. PMID: 40149320 Free PMC article. Review.

4

Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer.

Ladjevardi CO, Skribek M, Koliadi A, Rydén V, El-Naggar AI, Digkas E, Valachis A, Ullenhag GJ. Ladjevardi CO, et al. Among authors: skribek m. Cancer Immunol Immunother. 2024 Nov 7;74(1):14. doi: 10.1007/s00262-024-03869-1. Cancer Immunol Immunother. 2024. PMID: 39508883 Free PMC article.

5

Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar).

Grundberg O, Skribek M, Swerkersson S, Skorpil M, Kölbeck K, Grozman V, Nyren S, Tsakonas G. Grundberg O, et al. Among authors: skribek m. Eur J Radiol. 2024 Aug;177:111557. doi: 10.1016/j.ejrad.2024.111557. Epub 2024 Jun 9. Eur J Radiol. 2024. PMID: 38954912 Free article. Clinical Trial.

6

Osimertinib-induced syndrome of inappropriate secretion of antidiuretic hormone in oncogene-addicted lung adenocarcinoma: A case report.

Skribek M, Bozoky B, Tsakonas G. Skribek M, et al. Lung Cancer. 2022 Apr;166:132-134. doi: 10.1016/j.lungcan.2022.03.001. Epub 2022 Mar 5. Lung Cancer. 2022. PMID: 35276629 Free article.

7

Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals.

Skribek M, Brunnström H, Oskarsdottir G, Portu Grivé M, Aricak O, Planck M, Jatta K, Naserhojati H, Haglund de Flon F, Ekman S. Skribek M, et al. Acta Oncol. 2023 Dec;62(12):1808-1814. doi: 10.1080/0284186X.2023.2269310. Epub 2023 Nov 25. Acta Oncol. 2023. PMID: 37897706 Free article.

8

Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors.

Skribek M, Rounis K, Afshar S, Grundberg O, Friesland S, Tsakonas G, Ekman S, De Petris L. Skribek M, et al. Eur J Cancer. 2021 Mar;145:245-254. doi: 10.1016/j.ejca.2020.12.012. Epub 2021 Jan 5. Eur J Cancer. 2021. PMID: 33419647 Free article.

9

Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy.

Rounis K, Skribek M, Makrakis D, De Petris L, Agelaki S, Ekman S, Tsakonas G. Rounis K, et al. Among authors: skribek m. Cancers (Basel). 2021 Mar 29;13(7):1562. doi: 10.3390/cancers13071562. Cancers (Basel). 2021. PMID: 33805335 Free PMC article.

10

A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centers.

Zerdes I, Kamali C, Johannsdottir B, Blasi M, Assmann C, Kazdal D, Stenzinger A, Skribek M, Ekman S, Christopoulos P, Tsakonas G. Zerdes I, et al. Among authors: skribek m. Lung Cancer. 2025 Jan;199:108065. doi: 10.1016/j.lungcan.2024.108065. Epub 2024 Dec 17. Lung Cancer. 2025. PMID: 39705826 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year